 NEW YORK, Aug. 6, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intersect ENT, Inc. Intersect or the Company NASDAQ: XENT in connection with the proposed acquisition of the Company by Medtronic plc Medtronic NYSE:MDT. Under the terms of the merger agreement, the Companys shareholders will receive 28.25 per share in cash for each share of Intersect common stock that they hold. 